Nivolumab
From IDWiki
Revision as of 10:13, 17 July 2023 by Aidan (talk | contribs) (Created page with "* Immune checkpoint inhibitor targeting PD-1 * Indicated for melanoma, NSCLC, SCLC, RCC, Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma * Not particularly immunosuppressive * May increase risk of routine bacterial infections (including C. difficile), fungal infections (aspergillosis, pneumocystis, candidemia), viral infections (V...")
- Immune checkpoint inhibitor targeting PD-1
- Indicated for melanoma, NSCLC, SCLC, RCC, Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma
- Not particularly immunosuppressive
- May increase risk of routine bacterial infections (including C. difficile), fungal infections (aspergillosis, pneumocystis, candidemia), viral infections (VZV, CMV, EBV)
